Induction of apoptosis in circulating angiogenic cells by microparticles

Arthritis and Rheumatism

Volumn 63, Issue 7, 2011, Pages 2067-2077

  Distler, Jörg H W ^a   Akhmetshina, Alfiya ^a   Dees, Clara ^a   Jüngel, Astrid ^b   Stürzl, Michael ^a   Gay, Steffen ^b   Pisetsky, David S ^c   Schett, Georg ^a   Distler, Oliver ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CASPASE 3; GLYCEROPHOSPHOLIPID; PHOSPHATIDYLINOSITOL 3,5 BISPHOSPHATE; SPHINGOMYELIN PHOSPHODIESTERASE; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CIRCULATING ANGIOGENIC CELL; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; MALE; PARTICLE SIZE; PHAGOCYTOSIS; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; TRANSPORT KINETICS;

ADULT; ANNEXIN A5; APOPTOSIS; ARACHIDONIC ACID; CASPASE 3; CELL-DERIVED MICROPARTICLES; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; PHAGOCYTOSIS; SCLERODERMA, SYSTEMIC;

EID: 79959835842     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30361     Document Type: Article

References (45)

1. Sgonc R, Gruschwitz MS, Dietrich H, Recheis H, Gershwin ME, Wick G,. Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. J Clin Invest 1996; 98: 785-92. (Pubitemid 26349184)
2. Guiducci S, Distler O, Distler JH, Matucci-Cerinic M,. Mechanisms of vascular damage in SSc: implications for vascular treatment strategies. Rheumatology (Oxford) 2008; 47 Suppl 5: v18-20.
3. Maurer B, Busch N, Jungel A, Pileckyte M, Gay RE, Michel BA, et al. Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis. Circulation 2009; 120: 2367 - 76.
4. Beyer C, Schett G, Gay S, Distler O, Distler JH,. Hypoxia: hypoxia in the pathogenesis of systemic sclerosis. Arthritis Res Ther 2009; 11: 220.
5. Distler O, Del Rosso A, Giacomelli R, Cipriani P, Conforti ML, Guiducci S, et al. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Res 2002; 4: R11.
6. Distler O, Distler JH, Scheid A, Acker T, Hirth A, Rethage J, et al. Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis. Circ Res 2004; 95: 109-16. (Pubitemid 38931842)
7. Kuwana M, Okazaki Y, Yasuoka H, Kawakami Y, Ikeda Y,. Defective vasculogenesis in systemic sclerosis. Lancet 2004; 364: 603-10. (Pubitemid 39094178)
8. Distler JH, Akhmetshina A, Schett G, Distler O,. Monocyte chemoattractant proteins in the pathogenesis of systemic sclerosis. Rheumatology (Oxford) 2009; 48: 98-103.
9. Distler JH, Gay S, Distler O,. Angiogenesis and vasculogenesis in systemic sclerosis. Rheumatology (Oxford) 2006; 45 Suppl 3: iii26-7. (Pubitemid 44446772)
10. Gabrielli A, Avvedimento EV, Krieg T,. Scleroderma. N Engl J Med 2009; 360: 1989-2003.
11. Hirschi KK, Ingram DA, Yoder MC,. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2008; 28: 1584-95.
12. Mukai N, Akahori T, Komaki M, Li Q, Kanayasu-Toyoda T, Ishii-Watabe A, et al. A comparison of the tube forming potentials of early and late endothelial progenitor cells. Exp Cell Res 2008; 314: 430-40.
13. Distler JH, Beyer C, Schett G, Luscher TF, Gay S, Distler O,. Endothelial progenitor cells: novel players in the pathogenesis of rheumatic diseases [review]. Arthritis Rheum 2009; 60: 3168-79.
14. Urbich C, Dimmeler S,. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004; 95: 343-53. (Pubitemid 39100452)
15. Zammaretti P, Zisch AH,. Adult 'endothelial progenitor cells': renewing vasculature. Int J Biochem Cell Biol 2005; 37: 493-503. (Pubitemid 40022924)
16. Avouac J, Juin F, Wipff J, Couraud PO, Chiocchia G, Kahan A, et al. Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity. Ann Rheum Dis 2008; 67: 1455-60.
17. Del Papa N, Quirici N, Soligo D, Scavullo C, Cortiana M, Borsotti C, et al. Bone marrow endothelial progenitors are defective in systemic sclerosis. Arthritis Rheum 2006; 54: 2605-15. (Pubitemid 44205023)
18. Zhu S, Evans S, Yan B, Povsic TJ, Tapson V, Goldschmidt-Clermont PJ, et al. Transcriptional regulation of Bim by FOXO3a and Akt mediates scleroderma serum-induced apoptosis in endothelial progenitor cells. Circulation 2008; 118: 2156-65.
19. Distler JH, Pisetsky DS, Huber LC, Kalden JR, Gay S, Distler O,. Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases [review]. Arthritis Rheum 2005; 52: 3337-48. (Pubitemid 41612200)
20. Zwaal RF, Schroit AJ,. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997; 89: 1121-32. (Pubitemid 27079974)
21. Distler JH, Huber LC, Gay S, Distler O, Pisetsky DS,. Microparticles as mediators of cellular cross-talk in inflammatory disease. Autoimmunity 2006; 39: 683-90. (Pubitemid 44964371)
22. Guiducci S, Distler JH, Jungel A, Huscher D, Huber LC, Michel BA, et al. The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis. Arthritis Rheum 2008; 58: 2845-53.
23. Distler JH, Huber LC, Hueber AJ, Reich CF III, Gay S, Distler O, et al. The release of microparticles by apoptotic cells and their effects on macrophages. Apoptosis 2005; 10: 731-41. (Pubitemid 41187073)
24. Distler JH, Jungel A, Caretto D, Schulze-Horsel U, Kowal-Bielecka O, Gay RE, et al. Monocyte chemoattractant protein 1 released from glycosaminoglycans mediates its profibrotic effects in systemic sclerosis via the release of interleukin-4 from T cells. Arthritis Rheum 2006; 54: 214-25. (Pubitemid 43122204)
25. LeRoy EC, Medsger TA Jr., Criteria for the classification of early systemic sclerosis. J Rheumatol 2001; 28: 1573-6.
26. Distler JH, Allanore Y, Avouac J, Giacomelli R, Guiducci S, Moritz F, et al. EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells. Ann Rheum Dis 2009; 68: 163-8.
27. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, et al. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 1992; 99: 683-90. (Pubitemid 23002027)
28. Li ZD, Bork JP, Krueger B, Patsenker E, Schulze-Krebs A, Hahn EG, et al. VEGF induces proliferation, migration, and TGF-β1 expression in mouse glomerular endothelial cells via mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Biochem Biophys Res Commun 2005; 334: 1049-60. (Pubitemid 41074681)
29. Distler JH, Jungel A, Huber LC, Seemayer CA, Reich CF III, Gay RE, et al. The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles. Proc Natl Acad Sci U S A 2005; 102: 2892-7. (Pubitemid 40299887)
30. 2 via induction of cyclooxygenase 2 and microsomal prostaglandin E synthase 1. Arthritis Rheum 2007; 56: 3564-74. (Pubitemid 350100689)
31. Akhmetshina A, Dees C, Pileckyte M, Maurer B, Axmann R, Jungel A, et al. Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis. FASEB J 2008; 22: 2214-22. (Pubitemid 351948641)
32. Huber LC, Jungel A, Distler JH, Moritz F, Gay RE, Michel BA, et al. The role of membrane lipids in the induction of macrophage apoptosis by microparticles. Apoptosis 2007; 12: 363-74. (Pubitemid 46172422)
33. Kolzer M, Arenz C, Ferlinz K, Werth N, Schulze H, Klingenstein R, et al. Phosphatidylinositol-3,5-bisphosphate is a potent and selective inhibitor of acid sphingomyelinase. Biol Chem 2003; 384: 1293-8. (Pubitemid 37168697)
34. Wang E, Michl J, Pfeffer LM, Silverstein SC, Tamm I,. Interferon suppresses pinocytosis but stimulates phagocytosis in mouse peritoneal macrophages: related changes in cytoskeletal organization. J Cell Biol 1984; 98: 1328-41. (Pubitemid 14128917)
35. Weerheim AM, Kolb AM, Sturk A, Nieuwland R,. Phospholipid composition of cell-derived microparticles determined by one-dimensional high-performance thin-layer chromatography. Anal Biochem 2002; 302: 191-8. (Pubitemid 34229723)
36. Obeid LM, Linardic CM, Karolak LA, Hannun YA,. Programmed cell death induced by ceramide. Science 1993; 259: 1769-71. (Pubitemid 23114667)
37. Barry OP, Kazanietz MG, Pratico D, FitzGerald GA,. Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2- dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway. J Biol Chem 1999; 274: 7545-56.
38. Barry OP, Pratico D, Savani RC, FitzGerald GA,. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 1998; 102: 136-44. (Pubitemid 28323840)
39. Pfister SL,. Role of platelet microparticles in the production of thromboxane by rabbit pulmonary artery. Hypertension 2004; 43: 428-33. (Pubitemid 38174150)
40. Surette ME, Fonteh AN, Bernatchez C, Chilton FH,. Perturbations in the control of cellular arachidonic acid levels block cell growth and induce apoptosis in HL-60 cells. Carcinogenesis 1999; 20: 757-63. (Pubitemid 29191856)
41. Tsujii M, DuBois RN,. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995; 83: 493-501.
42. Jayadev S, Linardic CM, Hannun YA,. Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor α. J Biol Chem 1994; 269: 5757-63. (Pubitemid 24242948)
43. Marchesini N, Hannun YA,. Acid and neutral sphingomyelinases: roles and mechanisms of regulation. Biochem Cell Biol 2004; 82: 27-44. (Pubitemid 38580872)
44. Thevissen K, Francois IE, Winderickx J, Pannecouque C, Cammue BP,. Ceramide involvement in apoptosis and apoptotic diseases. Mini Rev Med Chem 2006; 6: 699-709. (Pubitemid 43881121)
45. Zeidan YH, Hannun YA,. The acid sphingomyelinase/ceramide pathway: biomedical significance and mechanisms of regulation. Curr Mol Med 2010; 10: 454-66.